Akoya Biosciences, Inc.s biggest owners are private equity firms who got richer after stock soared 18 percent last week

AKYA Stock  USD 2.71  0.01  0.37%   
About 58% of Akoya Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Akoya Biosciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Akoya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Akoya Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Key Insights Akoya Biosciences significant private equity firms ownership suggests that the key decisions are...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Akoya Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Akoya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Akoya Biosciences Fundamental Analysis

We analyze Akoya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akoya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akoya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Akoya Biosciences is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Akoya Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akoya Biosciences stock to make a market-neutral strategy. Peer analysis of Akoya Biosciences could also be used in its relative valuation, which is a method of valuing Akoya Biosciences by comparing valuation metrics with similar companies.

Peers

Akoya Biosciences Related Equities

INFUInfuSystems Holdings   10.07   
0%
100.0%
HAEHaemonetics   1.96   
0%
19.0%
ANGOAngioDynamics   1.49   
0%
14.0%
LMATLeMaitre Vascular   1.15   
0%
11.0%
COOCooper Companies,   1.04   
0%
10.0%
ATRAptarGroup   0.79   
0%
7.0%
UTMDUtah Medical   0.37   
0%
3.0%
ICUIICU Medical   0.14   
1.0%
0%
ATRCAtriCure   0.56   
5.0%
0%
PDEXPro Dex   2.76   
27.0%
0%
MLSSMilestone Scientific   4.04   
40.0%
0%

Complementary Tools for Akoya Stock analysis

When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities